The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb
Phase III, randomized trial (CheckMate 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non-squamous cell (non-SQ) non-small cell lung cancer (NSCLC).
 
Luis Paz-Ares
Honoraria - Roche/Genentech, Lilly, Pfizer, Boehringer, Clovis, BMS, MSD
 
Leora Horn
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Clovis Oncology; Helix BioPharma; Merck; Puma Biotechnology; Xcovery
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Hossein Borghaei
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genentech; Lilly
Research Funding - Millennium
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Genentech; Lilly
 
David R. Spigel
Stock and Other Ownership Interests - Foundation Medicine; Illumina
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Lilly; Novartis; Pfizer
Speakers' Bureau - Novartis
Research Funding - Amgen (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); BIND Biosciences (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); ImClone Systems (Inst); Immunogen (Inst); Lilly (Inst); Novartis (Inst); Oncogenex (Inst); OncoMed (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Biodesix; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Lilly; Novartis; Pfizer
 
Martin Steins
No Relationships to Disclose
 
Neal Ready
Consulting or Advisory Role - Bristol-Myers Squibb; Onyx
Research Funding - Bristol-Myers Squibb; Genentech
 
Laura Quan Man Chow
Honoraria - Amgen; Astellas Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly/ImClone (Inst); Merck (Inst); Novartis (Inst); OSI Pharmaceuticals (Inst); Pfizer (Inst); VentiRx (Inst)
Travel, Accommodations, Expenses - Merck; Novartis
 
Everett E. Vokes
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Celgene; Clovis Oncology; Eisai; GeneCentric; Genentech; Lilly; Merck; Synta; Transgene; VentiRx
 
Enriqueta Felip
Consulting or Advisory Role - Boehringer Ingelheim; lilly; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Novartis
 
Esther Holgado
Honoraria - Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Merck Serono; Roche
 
Fabrice Barlesi
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
 
Martin Kohlhaeufl
Speakers' Bureau - Boehringer Ingelheim; Cuiesi; Meda
Expert Testimony - Cuiesi
 
Oscar Rodriguez
No Relationships to Disclose
 
Marco Angelo Burgio
No Relationships to Disclose
 
Jerome Fayette
Leadership - Glycotope GmbH
 
Scott N. Gettinger
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Janssen
Research Funding - ARIAD (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Pfizer (Inst)
 
Christopher Harbison
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Cécile Dorange
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Abbott Diagnostics; Abbvie
 
Friedrich Graf Finckenstein
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Julie R. Brahmer
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck KGaA
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
Other Relationship - Bristol-Myers Squibb